Karine Paula Reichert

Karine Paula Reichert

Auto-generated profile, based on publicly available information

Karine Paula Reichert

Department of Biochemistry and Molecular Biology, Universidade Federal de Santa Maria, Santa Maria 97105-900, RS, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2018 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
KRKarine Paula Reichert
Karine Paula Reichert
MSMaria Rosa Chitolina Schetinger
Maria Rosa Chitolina Schetinger
JGJessie Martins Gutierres
Jessie Martins Gutierres
LPLuana Paula Pelinson
Luana Paula Pelinson
NSNaiara Stefanello
Naiara Stefanello
VMVera Maria Melchiors Morsch
Vera Maria Melchiors Morsch

30 July 2019 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
KRKarine P. Reichert
Karine P. Reichert
MSMaria Rosa C. Schetinger
Maria Rosa C. Schetinger
MPMicheli Pillat
Micheli Pillat
NBNathieli B. Bottari
Nathieli B. Bottari
TVTaís Vidal
Taís Vidal
VMVera Maria Melchiors Morsch
Vera Maria Melchiors Morsch

1 July 2020 in Chemosphere
Verified
Journal Article
Closed access
KRKarine P. Reichert
Karine P. Reichert
MPMicheli Pillat
Micheli Pillat
MSMaria Rosa C. Schetinger
Maria Rosa C. Schetinger
NBNathieli B. Bottari
Nathieli B. Bottari
TPTais V. Palma
Tais V. Palma
VMVera Maria Melchiors Morsch
Vera Maria Melchiors Morsch

1 March 2021 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
JCJuliane de Souza Cardoso
Juliane de Souza Cardoso
JBJucimara Baldissarelli
Jucimara Baldissarelli
KRKarine Paula Reichert
Karine Paula Reichert
FTFernanda Teixeira
Fernanda Teixeira
MSMayara Sandrielly Pereira Soares
Mayara Sandrielly Pereira Soares
RTRejane Giacomelli Tavares
Rejane Giacomelli Tavares

19 October 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ASAniélen D. da Silva
Aniélen D. da Silva
MFMateus Fracasso
Mateus Fracasso
NBNathieli B. Bottari
Nathieli B. Bottari
TPTaís V. Palma
Taís V. Palma
AEAna M. Engelmann
Ana M. Engelmann
ASALEKSANDRO S.Da Silva
ALEKSANDRO S.Da Silva
Background/Objectives: The Trypanosoma cruzi infection promotes an intense inflammatory process that affects several tissues. The cholinergic system may exert a regulatory immune response and control the inflammatory process. This study aimed to evaluate the comparative effect of free and nanoencapsulated benznidazole in acute T. cruzi infection to assess hematological, biochemical, and oxidative status triggered by the cholinergic system. Methods: For this, fifty female Swiss mice were distributed in eight groups, i.e., uninfected and infected animals under four treatment protocols: untreated (control—CT); vehicle treatment (Eudragit L 100—EL-100); benznidazole treatment (BNZ); and nanoencapsulated benznidazole treatment (NBNZ). After eight treatment days, the animals were euthanized for sample collection. Results: The peak of parasitemia was at day 7 p.i., and the BNZ and NBNZ controlled and reduced the parasite rate but showed no efficacy in terms of total elimination of parasites analyzed by RT-PCR in both infected groups. The infection promotes significant anemia, leukopenia, and thrombocytopenia, which the BNZ improves. There was an increase in AChE activity during infection, leading to a pro-inflammatory response and an increase in M1 and M2 mACh receptors in the BNZ group, showing that the treatment interacted with the cholinergic pathway. In addition, a pro-oxidative response was characterized in the infection and mainly in the infected BNZ and NBNZ groups. The histopathological analysis showed significative splenomegaly and inflammatory infiltrate in the heart, liver, and spleen. Conclusions: The administration of the BNZ or NBNZ reverses hematological, hepatic, and renal alterations through cholinergic signaling and stimulates a pro-inflammatory response during acute T. cruzi infection.